119th Congress · introduced in the House · Jul 22, 2025
End Prescription Drug Ads Now Act
Official title from Congress.gov
Latest action (Jul 22, 2025): Referred to the House Committee on Energy and Commerce.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
12 citations.
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · lobbying firm or registrant: AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Pharmacy
$3,010,000
Spent on own lobbying
…Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. "Buddy" - PBM contracting requirements and transparency H.R. 4605 - End Prescription Drug Ads Now Act - Rep. Nadler, Jerrold - Ban on DTC drug ads H.R. 4623 - Plain Prescription Prices Act - Rep. Williams, Nikema - Transparen…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
COALITION FOR HEALTHCARE COMMUNICATIONS · lobbying firm or registrant: COALITION FOR HEALTHCARE COMMUNICATIONS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 2, 2026 · issue area: Health Issues
Amount not reported
…) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. View filing
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · lobbying firm or registrant: AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Pharmacy
$3,010,000
Spent on own lobbying
…- Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. Buddy - PBM contracting requirements and transparency H.R. 4605 - End Prescription Drug Ads Now Act - Rep. Nadler, Jerrold - Ban on DTC drug ads H.R. 4623 - Plain Prescription Prices Act - Rep. Williams, Nikema - Transparen…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
COALITION FOR HEALTHCARE COMMUNICATIONS · lobbying firm or registrant: COALITION FOR HEALTHCARE COMMUNICATIONS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 6, 2026 · issue area: Health Issues
Amount not reported
…) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. View filing
COALITION FOR HEALTHCARE COMMUNICATIONS · lobbying firm or registrant: COALITION FOR HEALTHCARE COMMUNICATIONS
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted May 4, 2026 · issue area: Health Issues
Amount not reported
…) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. View filing
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · lobbying firm or registrant: AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Pharmacy
$5,320,000
Spent on own lobbying
…- Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. Buddy - PBM contracting requirements and transparency H.R. 4605 - End Prescription Drug Ads Now Act - Rep. Nadler, Jerrold - Ban on DTC drug ads H.R. 4623 - Plain Prescription Prices Act - Rep. Williams, Nikema - Transparen…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
HIMS & HERS HEALTH, INC. · lobbying firm or registrant: HIMS & HERS HEALTH, INC.
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · amended · posted Jan 23, 2026 · issue area: Health Issues
$330,000
Spent on own lobbying
…ssions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Presc…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · lobbying firm or registrant: AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 21, 2026 · issue area: Pharmacy
$4,120,000
Spent on own lobbying
…- Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. Buddy - PBM contracting requirements and transparency H.R. 4605 - End Prescription Drug Ads Now Act - Rep. Nadler, Jerrold - Ban on DTC drug ads H.R. 4623 - Plain Prescription Prices Act - Rep. Williams, Nikema - Transparen…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
COALITION FOR HEALTHCARE COMMUNICATIONS · lobbying firm or registrant: COALITION FOR HEALTHCARE COMMUNICATIONS
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 6, 2026 · issue area: Health Issues
Amount not reported
…) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. View filing
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · lobbying firm or registrant: AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Pharmacy
$4,230,000
Spent on own lobbying
…- Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. Buddy - PBM contracting requirements and transparency H.R. 4605 - End Prescription Drug Ads Now Act - Rep. Nadler, Jerrold - Ban on DTC drug ads H.R. 4623 - Plain Prescription Prices Act - Rep. Williams, Nikema - Transparen…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
COALITION FOR HEALTHCARE COMMUNICATIONS · lobbying firm or registrant: COALITION FOR HEALTHCARE COMMUNICATIONS
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Sep 18, 2025 · issue area: Health Issues
Amount not reported
…) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. View filing
COALITION FOR HEALTHCARE COMMUNICATIONS · lobbying firm or registrant: COALITION FOR HEALTHCARE COMMUNICATIONS
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Aug 5, 2025 · issue area: Health Issues
Amount not reported
…) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. View filing